| Literature DB >> 27798155 |
Geoffrey T Hart1, Munir Akkaya1, Asiya S Chida2, Chungwen Wei2, Scott A Jenks2, Christopher Tipton3, Chenfeng He4, Ben S Wendel5, Jeff Skinner1, Gunjan Arora1, Kassoum Kayentao6, Aissata Ongoiba6, Ogobara Doumbo6, Boubacar Traore6, David L Narum7, Ning Jiang4, Peter D Crompton1, Ignacio Sanz2, Susan K Pierce8.
Abstract
Plasmodium falciparum malaria is a deadly infectious disease in which Abs play a critical role in naturally acquired immunity. However, the specificity and nature of Abs elicited in response to malaria are only partially understood. Autoreactivity and polyreactivity are common features of Ab responses in several infections and were suggested to contribute to effective pathogen-specific Ab responses. In this article, we report on the regulation of B cells expressing the inherently autoreactive VH4-34 H chain (identified by the 9G4 mAb) and 9G4+ plasma IgG in adults and children living in a P. falciparum malaria-endemic area in West Africa. The frequency of 9G4+ peripheral blood CD19+ B cells was similar in United States adults and African adults and children; however, more 9G4+ B cells appeared in classical and atypical memory B cell compartments in African children and adults compared with United States adults. The levels of 9G4+ IgG increased following acute febrile malaria but did not increase with age as humoral immunity is acquired or correlate with protection from acute disease. This was the case, even though a portion of 9G4+ B cells acquired phenotypes of atypical and classical memory B cells and 9G4+ IgG contained equivalent numbers of somatic hypermutations compared with all other VHs, a characteristic of secondary Ab repertoire diversification in response to Ag stimulation. Determining the origin and function of 9G4+ B cells and 9G4+ IgG in malaria may contribute to a better understanding of the varied roles of autoreactivity in infectious diseases.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27798155 PMCID: PMC5113821 DOI: 10.4049/jimmunol.1600491
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422